Dr. Jim Tananbaum and the rest of the team at Foresite Capital added a real heavy hitter to their venture partnership this past week. Foresite Capital, a company most well known for their work in the healthcare field as a growth and equity firm has been making some major changes in 2017 and now they look more pried than ever for explosive growth. The new addition to Foresite Capital’s team is Dr. Molly He, formerly a senior director over at Illumina. Dr. He brings a whole wealth of experience and know-how to Foresite Capital and we are excited to dig into what makes her work so important.
To start things off, Dr. Jim Tananbaum wanted to make Dr. He feel welcomed. Tananbaum released a statement coinciding with Dr. He’s partnership. Dr. Tananbaum said, “Dr. He is one of the most respected scientific researchers in the area of next generation sequencing, and we are thrilled to welcome her to the team.” These kind words were more than a formality, they were well deserved. Dr. Tananbaum continued by praising Dr. He’s history in both genomics and drug development as well as her own incredible track record of company leadership. Dr. Tananbaum finished by saying, “She will be an invaluable resource to Foresite as we continue to expand and diversify our portfolio of transformational companies.”
Of course Dr. He isn’t one to let anyone else get all of the communications. The established doctor made sure to respond in kind to Dr. Tananbaum’s kind words. Dr. He applauded Foresite Capital for their ‘unparalleled reputation’ and called the company one of the most innovative healthcare companies around. Of course, Dr. He would have a great idea as to who was truly innovating in the healthcare industry. Dr. He spent a considerable amount of time at Illumina in charge of their innovation and improvements for the global protein reagent sector. She also worked with Pacific Biosciences as the head of protein reagent development. Dr. He’s excellent track record and Dr. Tananbaum’s ambition and excellence will lead Foresite Capital into a glowing and prosperous new year in 2017. More details can be found on Bloomberg.